John: Danaher and Cepheid will eventually respond to the TB test campaign because it will keep escalating (2023)
prediction · status: came true · last event: came true (2023-09-19) · owner: John · last mentioned: 2024-03-26
On 14 September 2023 John said Danaher and Cepheid had not responded to the TB test campaign but eventually would, because it would keep escalating. Five days later he reported that Danaher's standard TB cartridge would fall from $10 to $7.97, less than the hoped-for cut.
Told alongside: John asks viewers to press Danaher and Cepheid to cut GeneXpert TB test cartridges to $5 (2023)
About: Danaher Corporation, Cepheid
| date | event | what | video |
|---|---|---|---|
| 2023-09-14 | predicted | John says they have not heard from Danaher and Cepheid but will eventually, because the campaign will keep escalating. | Talking Tuberculosis, GeneXpert, J&J, and more with MY HEROES 00:39:11 |
| 2023-09-19 | came true | John reports that minutes before recording, USAID, the Global Fund and the Stop TB Partnership announced Danaher's standard TB cartridge would fall from $10 to $7.97, not the hoped-for 50% cut but significant. | So, um.... GOOD NEWS?!?!?! 00:00:00 |
| 2024-03-26 | recalled | John argues signing this petition is not a shout into the void: Danaher has responded to polite but insistent pressure, and such pressure seems the only way to change its system. | I Own Danaher 00:00:40 |
What is said about it
8 statements, by date (the events above are the turns of the thread; these are the details).
- 2023-09-19 · So, um.... GOOD NEWS?!?!?! — John says Danaher has committed to making no profit in poor countries from its standard TB cartridge. — 00:00:29
- 2023-09-19 · So, um.... GOOD NEWS?!?!?! — John has heard Danaher committed to regular third-party verification of its at-cost pricing, so the test price falls if manufacturing costs fall. (hedged) — 00:00:29
- 2023-09-19 · So, um.... GOOD NEWS?!?!?! — John says Danaher also agreed to improved maintenance conditions, making GeneXpert machines easier to fix when they break. — 00:00:29
- 2024-03-26 · I Own Danaher — John says Danaher charges an over 300% markup in the world's poorest countries for, say, an HIV test. — 00:01:09
- 2024-03-26 · I Own Danaher — John says poor communities, people with HIV (for whom quality testing is harder to access than it should be) and the social order do not benefit from the markup. — 00:01:09
- 2024-03-26 · I Own Danaher — John cites Partners In Health: in every country where it works, a lower cost per cartridge would let it expand access significantly. — 00:01:09
- 2024-03-26 · I Own Danaher — John argues most Danaher employees don't benefit either: Cepheid's workers went into lab and tech work to make transformative tests, not piles of money, and want maximal societal benefit. — 00:01:38
- 2024-03-26 · I Own Danaher — John says there is plenty of money to be made in rich countries to fund the research and the employees' livelihoods. — 00:01:38